Literature DB >> 17419625

Secretory phospholipase A2 hydrolysis of phospholipid analogues is dependent on water accessibility to the active site.

Günther H Peters1, Martin S Møller, Kent Jørgensen, Petra Rönnholm, Mette Mikkelsen, Thomas L Andresen.   

Abstract

A new and unnatural type of phospholipids with the head group attached to the 2-position of the glycerol backbone has been synthesized and shown to be a good substrate for secretory phospholipase A2 (sPLA2). To investigate the unexpected sPLA2 activity, we have compared three different phospholipids by using fluorescence techniques and HPLC, namely: (R)-1,2-dipalmitoyl-glycero-3-phosphocholine (hereafter referred to as 1R), (R)-1-O-hexadecyl-2-palmitoyl-glycero-3-phoshocholine (2R), and (S)-1-O-hexadecyl-3-palmitoyl-glycero-2-phosphocholine (3S). Furthermore, to understand the underlying mechanisms for the observed differences, we have performed molecular dynamics simulations to clarify on a structural level the substrate specificity of sPLA2 toward phospholipid analogues with their head groups in the 2-position of the glycerol backbone. We have studied the lipids above 1R, 2R, and 3S as well as their enantiomers 1S, 2S, and 3R. In the simulations of sPLA2-1S and sPLA2-3R, structural distortion in the binding cleft induced by the phospholipids showed that these are not substrates for sPLA2. In the case of the phospholipids 1R, 2R, and 3S, our simulations revealed that the difference observed experimentally in sPLA2 activity might be caused by reduced access of water molecules to the active site. We have monitored the number of water molecules that enter the active site region for the different sPLA2-phospholipid complexes and found that the probability of a water molecule reaching the correct position such that hydrolysis can occur is reduced for the unnatural lipids. The relative water count follows 1R > 2R > 3S. This is in good agreement with experimental data that indicate the same trend for sPLA2 activity: 1R > 2R > 3S.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17419625     DOI: 10.1021/ja067755b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  8 in total

1.  Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.

Authors:  Dipanjan Pan; Nibedita Sanyal; Anne H Schmieder; Angana Senpan; Benjamin Kim; Xiaoxia Yang; Grace Hu; John S Allen; Richard W Gross; Samuel A Wickline; Gregory M Lanza
Journal:  Nanomedicine (Lond)       Date:  2012-06-18       Impact factor: 5.307

2.  A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.

Authors:  Dipanjan Pan; Benjamin Kim; Grace Hu; Deepti Sood Gupta; Angana Senpan; Xiaoxia Yang; Anne Schmieder; Corban Swain; Samuel A Wickline; Michael H Tomasson; Gregory M Lanza
Journal:  Nanomedicine (Lond)       Date:  2015-01       Impact factor: 5.307

3.  Molecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.

Authors:  Lars Linderoth; Thomas L Andresen; Kent Jørgensen; Robert Madsen; Günther H Peters
Journal:  Biophys J       Date:  2007-09-07       Impact factor: 4.033

4.  Activation of phospholipase A2 by ternary model membranes.

Authors:  Adam Cohen Simonsen
Journal:  Biophys J       Date:  2008-01-30       Impact factor: 4.033

5.  Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.

Authors:  Hui-Fang Zhou; Huimin Yan; Angana Senpan; Samuel A Wickline; Dipanjan Pan; Gregory M Lanza; Christine T N Pham
Journal:  Biomaterials       Date:  2012-08-24       Impact factor: 12.479

Review 6.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

Review 7.  Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery.

Authors:  Dipanjan Pan; Christine T N Pham; Katherine N Weilbaecher; Michael H Tomasson; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-08-21

8.  Cellular Trafficking of Sn-2 Phosphatidylcholine Prodrugs Studied with Fluorescence Lifetime Imaging and Super-resolution Microscopy.

Authors:  Dolonchampa Maji; Jin Lu; Pinaki Sarder; Anne H Schmieder; Grace Cui; Xiaoxia Yang; Dipanjan Pan; Matthew D Lew; Samuel Achilefu; Gregory M Lanza
Journal:  Precis Nanomed       Date:  2018-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.